feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Dow futures slip after slide

trending

Google launches Gemini 3

trending

Malegaon girl raped, murdered

trending

Mumbai temperatures below normal

trending

Cloudflare outage affects ChatGPT

trending

Nikkei Index drops on US woes

trending

PM-Kisan installment on November 19

trending

Asian stocks, global market uncertainty

trending

Infosys share price positive return

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Baby Formula Linked to Deadly Botulism Outbreak

Baby Formula Linked to Deadly Botulism Outbreak

19 Nov

•

Summary

  • At least 23 babies have been hospitalized due to botulism.
  • The outbreak is linked to ByHeart powdered infant formula.
  • Botulism can cause paralysis and is potentially fatal if untreated.
Baby Formula Linked to Deadly Botulism Outbreak

The United States is currently facing a significant outbreak of botulism, with at least 23 infants diagnosed with the severe bacterial infection. All reported cases, occurring between August and November, have been traced to ByHeart powdered infant formula. The company has since issued a voluntary recall for all its products amid ongoing investigations by the FDA and CDC across 13 states.

Botulism is a rare but dangerous condition caused by toxins from Clostridium botulinum bacteria, which damage nerve cells. In infants, initial symptoms include constipation followed by progressive paralysis, potentially affecting head control, limb movement, and respiration. Prompt diagnosis and treatment with antitoxin are crucial, as the infection can be fatal if left untreated, although no deaths have been reported in this recent outbreak.

Health authorities are urging consumers to discard any ByHeart formula. This incident highlights concerns about food safety surveillance, particularly for low-moisture foods. While the recall is not expected to cause widespread shortages, it underscores a worrying trend in infant formula safety, following previous recalls by other major manufacturers due to different bacterial contamination.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Botulism is a rare nerve-damaging infection caused by toxins from Clostridium botulinum bacteria. In infants, it can lead to constipation, paralysis, and breathing difficulties.
The recent outbreak of botulism has been linked to ByHeart powdered infant formula, leading to a voluntary recall of all their products.
Infant botulism symptoms include constipation, weak cry, drooling, feeding difficulties, loss of head control, and progressive paralysis.

Read more news on

Healthside-arrow

You may also like

Smoking Rates Plummet Among Gen Z, But Influencers Threaten to Reignite the Trend

16 Nov • 11 reads

article image

FDA Eases Biosimilar Approvals, but Patent Hurdles Remain

14 Nov • 18 reads

article image

FDA Clears BrainsWay's Deep TMS System for Adolescent Depression Treatment

14 Nov • 24 reads

article image

Oral GLP-1 Drugs Poised to Reshape Obesity Treatment Landscape

14 Nov • 22 reads

Biocon Cuts Biosimilar Costs by 50% as US Eases Testing Rules

13 Nov • 29 reads

article image